177 related articles for article (PubMed ID: 15049785)
1. Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy.
Huang YM; Pirskanen R; Giscombe R; Link H; Lefvert AK
Scand J Immunol; 2004 Apr; 59(4):408-14. PubMed ID: 15049785
[TBL] [Abstract][Full Text] [Related]
2. Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy.
Sun Y; Qiao J; Lu CZ; Zhao CB; Zhu XM; Xiao BG
Clin Immunol; 2004 Sep; 112(3):284-9. PubMed ID: 15308122
[TBL] [Abstract][Full Text] [Related]
3. Circulating CD4+CD25+ T regulatory and natural killer T cells in patients with myasthenia gravis: a flow cytometry study.
Battaglia A; Di Schino C; Fattorossi A; Scambia G; Evoli A
J Biol Regul Homeost Agents; 2005; 19(1-2):54-62. PubMed ID: 16178275
[TBL] [Abstract][Full Text] [Related]
4. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
[TBL] [Abstract][Full Text] [Related]
5. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
[TBL] [Abstract][Full Text] [Related]
6. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
[TBL] [Abstract][Full Text] [Related]
7. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
Reinhardt C; Melms A
Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
[TBL] [Abstract][Full Text] [Related]
8. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis.
Monneret G; Debard AL; Venet F; Bohe J; Hequet O; Bienvenu J; Lepape A
Crit Care Med; 2003 Jul; 31(7):2068-71. PubMed ID: 12847405
[TBL] [Abstract][Full Text] [Related]
9. Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients.
Codarri L; Vallotton L; Ciuffreda D; Venetz JP; Garcia M; Hadaya K; Buhler L; Rotman S; Pascual M; Pantaleo G
J Exp Med; 2007 Jul; 204(7):1533-41. PubMed ID: 17591854
[TBL] [Abstract][Full Text] [Related]
10. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo.
Vukmanovic-Stejic M; Zhang Y; Cook JE; Fletcher JM; McQuaid A; Masters JE; Rustin MH; Taams LS; Beverley PC; Macallan DC; Akbar AN
J Clin Invest; 2006 Sep; 116(9):2423-33. PubMed ID: 16955142
[TBL] [Abstract][Full Text] [Related]
11. Decrease of CD4(+)CD25(high)Foxp3(+) regulatory T cells and elevation of CD19(+)BAFF-R(+) B cells and soluble ICAM-1 in myasthenia gravis.
Li X; Xiao BG; Xi JY; Lu CZ; Lu JH
Clin Immunol; 2008 Feb; 126(2):180-8. PubMed ID: 18054287
[TBL] [Abstract][Full Text] [Related]
12. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A
Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825
[TBL] [Abstract][Full Text] [Related]
13. Changes in thymopoiesis in myasthenia gravis.
Kosec D; Lavrnić D; Apostolski S; Leposavić G
Int J Neurosci; 2005 Feb; 115(2):223-43. PubMed ID: 15764003
[TBL] [Abstract][Full Text] [Related]
14. Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment.
Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Assunta B; Plantone D; Cammarota G; Tonali PA; Batocchi AP
Hum Immunol; 2009 Jun; 70(6):430-5. PubMed ID: 19364517
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+ CD25+ T cells.
Baecher-Allan C; Wolf E; Hafler DA
Clin Immunol; 2005 Apr; 115(1):10-8. PubMed ID: 15870015
[TBL] [Abstract][Full Text] [Related]
16. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
[TBL] [Abstract][Full Text] [Related]
17. Increase in differentiated type of T lineage cells in the myasthenic thymus: two-color fluorocytometric analysis.
Fujii N; Itoyama Y; Goto I
Ann Neurol; 1990 Jun; 27(6):642-6. PubMed ID: 2113791
[TBL] [Abstract][Full Text] [Related]
18. Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells.
Jakubíková M; Piťha J; Marečková H; Týblová M; Nováková I; Schutzner J
J Neurol Sci; 2015 Nov; 358(1-2):101-6. PubMed ID: 26320610
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent.
Valzasina B; Piconese S; Guiducci C; Colombo MP
Cancer Res; 2006 Apr; 66(8):4488-95. PubMed ID: 16618776
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody analysis of blood T-cell subsets in myasthenia gravis.
Skolnik PR; Lisak RP; Zweiman B
Ann Neurol; 1982 Feb; 11(2):170-6. PubMed ID: 6462101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
